Caroline Baumal, Chief Medical Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 2,797 shares at $21.77 ($61K) on 2026-01-22, disclosed to the SEC on 2026-01-23.
Seasonal sale ($61k) by Chief Medical Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2025-01-21 | $111K | — | Filing → |
| APLS | SELL | 2025-01-08 | $190K | — | Filing → |
| APLS | SELL | 2024-01-05 | $330K | — | Filing → |